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Classical pathway of complement activation in normal and diseased
human glomeruli. Monoclonal antibodies (mAb) reactive against com-
plement components involved in the classical activation pathway were
applied in an indirect immunoperoxidase technique for the histological
study of normal and diseased human renal tissues. Prominent staining
with antibodies against the C4d fragment was seen in all glomeruli and
some renal arteriolar walls. The C4d staining was mesangial with light
microscopy, whereas the subendothelial site of the glomerutar base-
ment membrane (GBM) also appeared to be positive in immunoelectron
microscopy. In similar localization, albeit with distinctly weaker inten-
sity, 1gM and C4 binding protein (C4bp) were detected. In kidney
biopsies from patients with various types of glomerulonephritis, C4d
reactive antibodies stained the glomerular structures in a strong, diffuse
or granular pattern in contrast to the more segmental distribution and
weaker staining intensity in normal kidney specimens. Increased
amounts of C4d, occasionally also of C4b, were paralleled in diseased
kidney tissues by distinct deposits of 1gM and/or IgG in the presence of
C4bp. This study suggests that the C4d fragment in normal human
glomeruli is indicative of a continuous, local complement activation via
the classical pathway induced by the physiological deposition of 1gM-
containing immune complexes.
Complement activation in glomeruli is supposed to result in
tissue damage by formation of the membrane attack complex,
enhancement of phagocytosis and promotion of the inflamma-
tory response by the release of anaphylatoxins [1—31. Comple-
ment can be activated either via the classical pathway by
antibody-coated targets, by immune complexes (ICs) or via the
alternative pathway in the absence of antibody [4, 5]. Both
pathways result in C3 activation and covalent binding of C3b
fragments to target structures via their internal thiolester 16, 7].
The characteristic step in classical pathway activation is the
covalent binding of reactive C4b fragments to activating or
closely neighboring structures on ICs or antibody-coated tar-
gets. Regulatory proteins such as complement receptor type 1,
decay accelerating factor, glycoprotein 45-70, C4bp, factor H or
factor I control the complement cascade by cleavage of acti-
vated complement components 18].
Recently, the demonstration of complement components in
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diseased human kidneys has been extended to C3d fragment
and C5b-9 complex deposition [9, 10]. However, the detection
of these complement activation products also in non-diseased
kidney tissue without the simultaneous deposition of ICs [11]
raised new questions concerning the mechanism of complement
activation and its function in mediating tissue damage. In
addition, the presence of both isotypic components of comple-
ment C4, C4A and C4B, in normal human glomeruli and some
renal interstitial arterioles has been observed [12]. In the
present study, we were interested in further characterization of
origin and function of the glomerular C4 compound. We applied
a panel of mono- and polyclonal antibodies on cryostat sections
of normal and diseased human kidney tissues. We demonstrate
that: 1) the glomerular C4 compound can be characterized as
the C4d fragment that is covalently bound in the mesangium and
along the glomerular basement membrane; and 2) low amounts
of 1gM and C4bp parallel glomerular C4d deposition. The
hypothesis of a continuous, local complement activation via the
classical pathway induced by physiological 1gM-complex dep-
osition in normal human glomeruli is corroborated by the study
of diseased kidney tissue with glomerulonephritis.
Methods
Monoclonal antibodies against complement component C4
Monoclonal antibodies (mAb) were raised in female BALB/c
mice by immunization with affinity-purified human C4 as de-
scribed in detail elsewhere [13]. The reactivity of the antibodies
was determined in a C4-ELISA and by Western-blot analysis.
Thus, antibody M4a1 is reactive with the C4a (a1—) fragment,
M4c 1 with the p-chain, M4c3 with the y-chain and M4d1 with
the C4d (a2—) portion of complement C4 [13]. The reactivity of
additional antibodies M4c2 (p-chain), M4d2 and M4d3 (a2—
portion) is shown below.
Commercially purchased antibodies
The following antibodies have been purchased and applied in
indirect immunoperoxidase staining and/or immunoblotting:
two different rabbit antisera to human C4 (Dakopatts, Ham-
burg, FRG; Calbiochem-Behring, Frankfurt, FRG), goat anti-
serum to human C4 (Atlantic Antibodies, Scarborough, USA),
mAb to C4d, mAb to C4c and mAb to C4bp (Cytotech, San
Diego, California, USA), polyclonal antiserum to C4bp (Calbi-
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ochem), two mAbs reactive against human IgG and 1gM,
respectively (Dianova, Hamburg, FRG), mAb to 1gM (Nordic,
Hamburg, FRG), polyclonal antisera against human IgG or 1gM
(Dakopatts). Peroxidase coupled antisera to rabbit or mouse Ig
(Dakopatts) were applied as second antibodies in indirect
immunoperoxidase and immunoblotting reactions.
Isolation of C4 and its cleavage fragments by
immunoprecipitation
Native C4 and its split product C4d were isolated using a
modified immunomatrix as described in detail elsewhere [13,
14]. In short, native C4 protein was precipitated in human
EDTA-plasma with rabbit antiserum against human C4 (Dako-
patts) coupled to protein A-Sepharose (PAS) beads (Pharmacia,
Freiburg, FRG). C4 protein was eluted with 50 mi dieth-
ylamine (Sigma) and neutralized with 0.5 M NaH2PO4. Contam-
inating immunoglobulins were removed by PAS and the purity
of C4 was assessed by SDS-PAGE. The C4d fragment was
generated in human serum by incubation with heat aggregated
IgG [15]. C4d was likewise immunoprecipitated in activated
serum by a sandwich complex consisting of PAS beads, rabbit
antiserum to mouse Ig (Dakopatts) and ascites fluid of the
a2-specific mAb M4d 1. The C4a fragment was generated by
cleaving affinity-purified C4 with the C1 component of Cl. The
Cl fraction was isolated by affinity chromatography according
to the method of Assimeh, Bing and Painter [161.
SDS-PAGE and immunoblotting
SDS-PAGE was performed according to the method of
Laemmli [17]. To reduce proteins, samples were boiled for
three minutes in the presence of 2% 2-ME (Sigma). Afterwards,
the proteins were blotted onto nitrocellulose paper (Schleicher
and Schuell, Dassel, FRG) in 25 mM Tris/HCI, ph 9.0, 192 mM
glycine, 20% (vol/vol) methanol for two hours at 30 V at room
temperature [18]. The nitrocellulose paper was washed and
incubated in a first step with adequately diluted antisera or
hybridoma supernatants. Then peroxidase conjugated second
antibody, either rabbit anti-mouse 1g. swine anti-rabbit 1g. or
rabbit anti-goat Ig (Dakopatts) was added. The peroxidase
activity was assayed with nitroprusside-Na (Sigma), o-dianisi-
dine (Sigma) and H202 (Merck, Darmstadt, FRG).
Tissue specimens
Morphologically normal, adult renal tissue was obtained from
unaffected parts of 14 nephrectomies performed for localized
renal carcinoma. Samples were immediately (2 to 10 mm after
organ resection) snap-frozen in liquid nitrogen and stored at
—80°C until preparation of cryostat sections. Intraoperative
kidney biopsies were taken from two children, four months and
five years old, respectively, who suffered from obstructive
ureteral stenosis. One renal tissue probe was obtained from a
22-week-old embryo due to legal abortion. All these samples
appeared normal on light microscopic examination and, with
the exception of one nephrectomy sample, did not demonstrate
IC deposition on immunofluorescence examination. Percutane-
ous kidney biopsies from 40 adult patients suffering from
glomerulonephritis were obtained between January and April
1986. All biopsies were evaluated and characterized by direct
immunofluorescence carried out with FITC-labeled polyclonal
antisera to human IgG, 1gM, IgA, C3, C4, albumin and fibrin-
ogen [191. These immunohistochemical results will not be
described in this paper.
Immunoperoxidase microscopy
Immunoperoxidase staining was performed with modifica-
tions as described in detail elsewhere [20]. In brief, 5 m
cryostat sections were cut using a Frigocut Mod. 2700 (Re-
ichert-Jung, NuBloch, FRG). Sections were air-dried for five
hours followed by a three minute fixation in cold acetone. They
were then incubated with appropriately diluted first antibody
for 45 minutes. After a washing step in PBS the peroxidase-
conjugated second antibody was incubated for another 30
minutes. After final washing in PBS the sections were stained
with 3-amino-9-ethylcarbazole (Sigma), DMSO (Merck) and
H202 in PBS. Counterstaining was performed in hemalaun
(Merck), As a control, sections were incubated with non-
immune rabbit IgG and with supernatants from irrelevant
mouse hybi-idomas.
Immunoelectron microscopy
Normal parts from three nephrectomies were examined.
Whole glomeruli were isolated from freshly obtained ice-cooled
renal cortex by subsequent sieving through meshes of different
pore size [21]. Glomeruli were fixed at room temperature in 0.1
M cacodylate buffer pH 7.4 containing 2% formaldehyde and
0.1% glutaraldehyde for five minutes. Longer fixation period
and increased concentration of fixative resulted in loss of
antigenicity. Glomeruli were washed in PBS and 'quenched' in
1 mM NH4CI followed by a single freezing-thawing step. Alter-
natively, small renal cortex specimens were immediately fixed
for five minutes (see above), washed, 'quenched' and cut into
20 m sections. Both preparations were then incubated with
optimal dilutions of mAbs reactive against C4d (M4d1) and C4c
fragment (M4c1) for 20 hours at room temperature. After
washing in PBS overnight, sections were incubated with per-
oxidase-conjugated rabbit antiserum to mouse Ig (Dakopatts)
for another 20-hour incubation period. After a final washing
step of 24 hours, peroxidase activity was revealed by reaction
with diaminobenzidine (Sigma) and H202 [22]. Sections were
postfixed with 1% unbuffered 0S04, dehydrated and flat embed-
ded in Epon. Ultrathin sections were cut using a Reichert
Ultracut E and examined with a Siemens Elmiskop I or 102
(Siemens, München, FRG).
Elution of complement fragments from tissue sections
Elution experiments were performed applying; a) 0.05 M
citrate buffer pH 3.3; b) 0.5 M, 1.054 or 1.5 M NaCI solutions on
sections from normal and diseased kidney tissue. The sections
were incubated for 30 minutes at room temperature with a final
washing step in PBS, followed by the described indirect immu-
noperoxidase staining procedure.
Results
Reactivity of antibodies against C4
Reactivity of mAbs against the a-, /3- and y-chain of C4 and
the cleavage fragment C4d (a2) is demonstrated in Figure 1A.
Antibodies M4dl, M4d2, M4d3 as well as a commercial mAb
anti-C4d reacted with the a-chain and the C4d fragment.
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a3, a4, /3, y) and C4a (a1) is demonstrated in Figure lB. MAb
M4dl reacted with whole C4 and with C4b. MAb M4a1 reacted
with whole C4 and the C4a-fragment (* represents a band
produced by contaminating C4c' (/3, a1, a3, a4, y). The polyva-
lent goat anti-C4 also reacted with C4a.
Binding sites of mAbs on the C4 molecule are schematically
illustrated in Figure 2.
Immunoperoxidase microscopy
Immunohistological staining results are schematically dem-
onstrated in Figure 3.
Normal kidney tissue
Fig. 1. Reactivity of different anti-C'4 antibodies determined by West-
ern blot analysis. (A) A mixture of immunoprecipitated C4 and C4d was
analyzed in SDS-PAGE (10%) under reducing conditions. After blot-
ting, identical lanes were incubated with rabbit antiserum to C4
(Dakopatts) or the different C4 specific mAbs (lane 1: polyvalent goat
anti-C4; 2: polyvalent rabbit anti-C4; 3: M4d1; 4: M4d2; 5: M4d3; 6:
commercial mAb anti-C4d; 7: M4c1; 8: M4c2; 9: commercial mAb
anti-C4c; 10: M4c3). (B) Immunoprecipitated C4 was cleaved by Cis
and separated on a 3.5 - 20% SDS-PAGE under non-reducing condi-
tions. After blotting the lanes were incubated with: lane I: polyvalent
goat anti-C4; lane 2: M4d1; lane 3: M4a1 [* represents C4c' (/3, a, a3,
a4,
Antibodies M4c1, M4c2 and a commercial mAb anti-C4c re-
acted with the /3-chain. Antibody M4c3 reacted exclusively with
the y-chain. It was shown by cross-blocking experiments that
a2- and /3-specific mAbs reacted with different epitopes (data
not shown). Two commercial polyvalent antisera against C4
(goat anti-C4; rabbit anti-C4) reacted with the a-, /3- and
y.chain; they did not, however, recognize the C4d fragment.
The reactivity of mAbs against the cleavage fragments C4b (a2,
C4 reactive antibodies: Application of /3- or y-chain specific
mAbs and of commercially available antisera to human C4
failed to stain 13 out of 14 normal human kidney sections (Fig.
4C). In addition, no C4a antigen was detected with mAb M4a1.
Exclusively C4d fragment specific mAbs (M4d1, M4d2, M4d3,
commercially available mAb anti-C4d) stained all human gb-
meruli and some renal arteriolar walls in the examined normal
kidney tissues (Fig. 4A). Occasionally, there was predominant
staining of arteriolar parts of the vascular pole. The pattern of
positive gbomerular staining reaction could be described as
granular and segmental in mesangial and capillary areas.
Whether the positive staining reaction of arteriolar walls be-
longed to vascular poles of adjacent glomeruli could not be
assessed. Other vascular elements as well as constituents of the
tubular system were, however, consistently negative as de-
scribed previously [12].
C4bp reactive antibodies. In 12 out of 14 cases antigens of
C4bp were observed in similar glomerular localization to C4d
fragment deposition applying poly- and monoclonal anti-C4bp
antibodies (Fig. 4B). Compared to the C4d deposition, the
staining intensity for C4bp was clearly weaker. Comparative
study with mono- and polyclonal antibodies against C4bp
revealed lower sensitivity of the latter in antigen detection. In
two cases only scarce glomerular distribution of C4bp occurred
that could not be detected by the polyclonal reagent.
1gM reactive antibodies. Application of two mAbs resulted in
similar staining patterns. Nine out of 14 tissue probes displayed
a weak to moderate 1gM antigen deposition comparable to C4d
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Fig. 2. Schematic diagram of the molecular structure of human C4
protein. Arrows indicate the epitopes recognized by representative
mAbs with reactivity against C4 (* represents the internal thiolester
bond which mediates covalent linkage of the C4b/d fragment to target
molecules).
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demonstrated in kidney sections from two children, four
months and five years old.
Diseased human kidney tissue
Fig. 3. Co-deposition of 4d and C4b with C4bp, 1gM and iga in
tissue specimens from normal human kidneys (A) and from various
glomerulonephritides (B-E). Range of staining intensity: 0 absent, 1+
moderate, 2+ moderate to strong, 3+ strong to 4+ very strong; there
was intermediate rating if indicated ('/2+ weakly positive, etc.) Ciphers
under the columns indicate the number of cases or the age of the
patient. I indicates the range of variability when 2 cases or more are
summarized. Abbreviations are: SLE, systemic lupus erythematosus;
MPGN, membranoproliferative glomerulonephritis; MGN, mesangial
proliferative glomerulonephritis; GPN, Goodpasture nephropathy;
RPGN, rapidly progressive glomerulonephritis; FGS, focal glomerular
sclerosis; MN, membranous nephropathy; MCNS, minimal-change
nephrotic syndrome; SHN, SchOnlein-Henoch nephropathy. Symbols
are: (1111) C4d; (fl) C4bp; () C4b; (Lfl 1gM; (D) IgG.
and C4bp in its glomerular localization. The amount of antigen
was similar to C4bp or less (Fig. 4D). When the polyclonal
antiserum against 1gM was used, only four sections could be
judged as positive. Hereby, evaluation was complicated by a
distinct staining background that was not seen with the mono-
clonal reagents. It should be noted that the direct immunofiuo-
rescence examination of 14 normal kidney probes had consis-
tently been negative for 1gM with the exception of one section,
being modestly 1gM positive. In this case we were able to
demonstrate increased deposition of C4d, C4bp, 1gM and even
traces of C4b applying the mAbs. The 22-week-old embryonic
renal tissue displayed negative histological staining results.
Interestingly, distinct glomerular deposition of C4d and to a
less extent of 1gM and C4bp antigens, respectively, could be
Biopsies from 40 patients with different types of glomerulo-
nephritis were examined. The following diagnoses (based on
clinical, immunomorphological and histopathological findings)
had been raised: minimal-change nephrotic syndrome (MCNS,N = 2), membranoproliferative glomerulonephritis type I
(MPGN, N = 1), SLE (systemic lupus erythematosus) nephrop-
athy (N = 7), focal glomerular sclerosis (FGS, N = 5),
IgA-nephritis (N = 13), mesangial proliferative glomerulone-
phritis (MGN, N = 5), Schönlein-Henoch nephropathy (SHN,N = 2), membranous nephropathy (MN, N = 1), rapidly
progressive glomerulonephritis (RPGN, N = 2), and Goodpas-
ture nephropathy (GPN) (N = 2). Sections were investigated for
deposition of C4c (by mAb M4c1), C4d (mAb M4d1), C4bp
(mAb, Cytotech) and concomitant IgM/G (mAbs purchased
from Dianova) by indirect immunoperoxidase microscopy. C4a
antigen could never be detected as assessed by mAb M4a1.
Positive staining of mAb M4d1 in the absence of C4a and C4c
indicated deposition of C4d. In contrast, the presence of C4c
and C4d in the absence of C4a strongly suggested deposition of
C4b.
IgA nephritis (N = 13). Eight cases displayed modest C4d
deposition comparable to normal kidney tissue. All of these
were accompanied by C4bp deposits and in six by low amounts
of 1gM, and one biopsy additionally displayed IgG antigens. In
four patients, C4b and increased quantities of C4d, respec-
tively, were detected in the presence of distinct C4bp and 1gM
deposits. Finally in one case increased quantities of C4d and
1gM were paralleled by only weak staining for C4bp in the
absence of C4b.
SLE nephropathy (N = 7; Fig. 5A, B, C). In all examined
cases the presence of C4b was accompanied by deposition of
IgG and/or 1gM and distinct amounts of C4bp.
For the immunohistological characterization of MGN (Fig. 5
D, E, F), GPN, RPGN, FGS, MN (Fig. 6A, B, C), MCNS,
SHN and MPGN (Fig. 6D, E, F), refer to Figure 3. It is
noteworthy that C4b deposition was accompanied by demon-
stration of 1gM and/or IgG regardless of diagnosis, staining
intensity and antigen localization. This is not surprising since
ICs are thought to be causative for the activation of the classical
complement pathway [23]. In addition, C4b always coincided
with increased amounts of C4bp. In only one case (MGN)
increased C4bp deposits were demonstrated in the absence of
C4b antigen.
Elution studies
To examine whether the complement components C4b and
C4d would bind covalently or non-covalently to tissue struc-
tures, elution studies were performed. Treatment of unfixed
normal kidney sections with 1,5 M NaCI solution or citrate
buffer of pH 3.3 resulted in only slight diminution of the C4d
staining intensity. Three cases of glomerulonephritis with dis-
tinct deposition of C4b were equally treated and displayed a
slight decrease of antigen reactivity.
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Fig. 4. Staining of normal human kidney sections. (A) Segmental and granular glomerular distribution of C4d (M4d1). (B) Weakly positive staining
reaction for C4bp (mAb), note the segmentally labeled glomerular capillary wall. (C) Absence of C4b antigen (M4c1). (D) Weak but distinctly
positive labeling for 1gM (mAb).
Fig. 5. Renal biopsies from one SLE patient (upper series) and one patient with mesangial proliferative g!omerulonephritis (lower series). Sections
from SLE nephropathy displayed distinct deposition of C4d (A, M4dl), C4bp (B, mAb) and C4b (C, M4c1). The patient with MGN had strong
mesangial deposits of C4d (D, M4dl), but normal levels of C4bp (E, mAb) in the absence of C4b (F, M4c1).
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Fig. 6. Biopsies from patients with membranous glomerulonephritis (upper series) and membranoproliferative glomerulonephriris (lower series).
Thepatient with MN displayed strong labeling for C4d (A, M4dl), moderate deposits of C4bp (B, mAb) in the absence of C4b (C, M4c1). In MPGN,
distinct deposits of C4d (D, M4d1) and C4bp (E, mAb) were paralleled by low amounts of C4b (F, M4c1).
Immunoelectron microscopy C4d antigen was found to be predominantly located at the
Normal parts from three nephrectomies were examined by subendothelial site of the glomerular basement membrane
immunoelectron microscopic examination. With this technique, (GBM) showing a gradient of decreasing intensity towards the
epithelial site (Fig. 7). A mesangial staining pattern, as apparent
in immunoperoxidase light microscopy, could not be seen in
immunoelectron microscopy.
Discussion
In the present study, the previously described [121 glomerular
C4 compound could be characterized as the C4d cleavage
fragment by the use of mAbs on cryostat sections of normal
kidney tissue. Thus, the commonly encountered negative un-
munohistological staining results with polyvalent antisera
against C4 can be explained by their failure to recognize the C4d
(a2) fragment (Fig. 1). Unaffected parts from kidney tissue
obtained during tumor nephrectomies have been widely used to
investigate the distribution of normal renal antigens, including
complement components also in other studies [11, 24]. Since
the classical pathway of complement activation is generally
induced by ICs [5, 23, 251, the question appeared whether C4d
deposition in normal glomeruli was also connected with IC
formation. For the immunohistochemical demonstration of ICs
we therefore applied mAbs with specificity for 1gM or IgG in
comparison to conventionally used polyclonal antisera. No IgG
antigens were detected irrespective of the applied antibodies.
However, a surprisingly clear difference in sensitivity was
found in the detection of 1gM by either mono- or polyclonal
reagents (11 vs. 4 positive staining reactions). Benefits of the
Fig. 7. Deposition of 4d in immunoelectron microscopy. Staining introduction of mabs into immunohistochemistry are well rec-
reaction with monoclonal M4d1 occurred predominantly along the ognized [26]. The main obstacle of the polyclonal antiserum
subendothelial site (arrow) of the glomerular basement membrane. used was a distinct staining background, that could only be
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abolished using very high antibody dilutions. Unspecific stain-
ing reactions might indeed be causative for a remarkable lack of
sensitivity of conventional antisera in comparison to mAbs. The
occurrence of Ig deposits in normal human kidney tissue is
controversially discussed. In general, glomerular ICs are con-
sidered as being pathologic [19]. However, by the application of
fluoresceinated (FITC) antisera, glomerular immune deposits
(1gM and/or IgG) have been detected in patients with no clinical
or light microscopic evidence of glomerulonephritis in up to
39% of cases [27, 281. Differences in antigen specificity of the
antisera could very well explain the divergent results. In mice.
an ubiquitous glomerular presence of ICs (IgG and/or 1gM) has
been demonstrated in animals with high and permanent expo-
sure to foreign infective agents [291. In contrast, animals grown
in a germ-free environment showed a much lower incidence of
deposits. Furthermore, previous experimental observations in
mice suggest that trapping and deposition of preformed, p1] -
neutral ICs occurs only temporarily in glomeruli [30, 31]. In
addition, the binding of Clq, that is associated with ICs, to
laminin [32] and fibronectin [331, which are both constituents of
basement membranes, is well established and could provide the
basis for retention of ICs at the GBM. Thus, complement
deposition via activation of the classical pathway in glomeruli
and renal arteriolar walls possibly takes place as a result of the
transient glomerular deposition and clearance of low amounts
of antigen-antibody complexes formed during natural antibody
response in vivo [29]. This deposition may either occur in the
mesangium or along the GBM. Glomerular C4d deposits most
likely represent stable C4d-IgM complexes [5] as well as
covalently bound C4d fragments in close vicinity to the activat-
ing immune deposits. The preponderance of C4d in comparison
to local 1gM deposits could thus be explained, and also by a
rather slow turnover of such C4d molecules that are covalently
bound to glomerular structures. The reasons why the indirect
immunoperoxidase techniques show predominantly mesangial
C4d with light microscopy whereas subendothelial C4d appears
in electron microscopy, are not entirely clear. Several technical
differences in the processing of the tissue samples could be
considered, for example, long incubation periods and possible
diffusion of the DAB product [34] out of the mesangium with
immunoelectron microscopy.
An alternative explanation for the glomerular deposition of
C4d could be the passive absorption of circulating C4d gener-
ated during systemic complement activation. However, a re-
cent study investigating the binding specificities of C3d in
normal glomeruli made passive absorption of C3d highly un-
likely but favored more specific interactions with the GBM [24].
Also in our study, treatment of unfixed normal kidney sections
with low pH or high salt concentration resulted in only a slight
diminution of glomerular C4d antigen. We conclude that the
majority of C4d is covalently bound to the glomerular basement
membrane and thus indicates complement activation via the
classical pathway in close proximity. Furthermore, our hypoth-
esis of a local, IC-mediated complement activation is corrobo-
rated by the detection of glomerular C4bp similar in localization
to C4d. C4bp binds to C4b as a cofactor for cleavage of C4b into
C4d and C4c by factor I [35, 36]. We suggest that C4bp
accumulates locally at the site of complement consumption and,
after cleavage of the C4b-C4bp complex, disappears slowly due
to its high molecular wt (550 kD). It should be noted, that a very
similar histologic picture, that is, association of C4d and C4bp
with 1gM (in the absence of C4a and C4c), is observed in human
lymphoid germinal centres, where ICs are retained on follicular
dentritic cells [13].
Despite the simultaneous detection of 1gM in 9 out of 14
probes of normal kidney tissue, a direct, spontaneous activation
of the classical complement pathway along the GBM indepen-
dently from prior Ig attachment can not be completely ex-
cluded. Cardiolipin from mitochondrial membranes, vascular
endothelium, DNA, RNA, the myclin basic protein, retrovi-
ruses and other agents have been shown to represent antibody-
independent activators of the classical complement pathway
[37, 38]. Yet, the subendothelial localization of C4d as shown in
immunoelectron microscopy clearly corresponds to the suben-
dothelial electron-dense deposits in glomeruli of mice after
injection of ICs [30].
The investigation of diseased kidney tissue provided addi-
tional arguments for the IC-mediated C4d deposition in normal
human glomeruli. In all eight cases of SLE nephropathy and
MPGN, abundant deposition of C4d and C4b, respectively, was
accompanied and presumably caused by ICs via activation of
the classical pathway. In addition, glomerular appearance of
C4b fragment, as judged by the simultaneous detection of C4c
and C4d antigens, was invariably paralleled by an increase in
glomerular 1gM and/or IgG. Presence of C4b might therefore
indicate the very acute phase of complement activation induced
by IC deposition in close proximity (Fig. 5A-C). On the
contrary, abundant glomerular C4d in the absence of C4b
antigen suggests classical complement activation returning to
physiological levels (Fig. 6A-C).
As would be predicted, the amount of C4bp detected in
diseased kidney tissue varied with the appearance of C4b
antigen. Taken together, higher quantities of C4d were paral-
leled by increased 1gM and/or IgG deposition. The amount of
C4bp, however, closely followed the appearance of C4b. The
C4b-C4bp complex can therefore be regarded as a histological
marker of disease activity whenever the classical pathway of
complement activation is involved. Its significance for the
evaluation of complement activation in the fluid phase has been
stated elsewhere [39]. Definite Ig-induced classical complement
activation has recently been observed in idiopathic membra-
nous glomerulonephritis also by other investigators [40].
Several authors have already reported complement activation
in normal human kidney tissue [9, 11]. However, complement
proteins C3d, factor H and C5b-9 complex were localized to all
renal connective matrices, that is, arteriolar media, glomerular
and tubular basement membranes and mesangial matrix. Ultra-
structurally, cell membranes shed from adjacent cells could be
identified as the most probable target structure. Vascular C5b-9
deposits were recently correlated to the development of arte-
riosclerosis [41, 42] and a similar process, that is, activation by
cell debris, was suggested for the kidney. In contrast to C3d and
C5b-9, C4d deposition representing the classical pathway of
complement activation, is strictly confined to glomerular and
few renal arteriolar structures and coincides with 1gM-com-
plexes. Therefore, from our data a clear discrimination between
complement activation via the alternative and the classical
pathway operating in different renal compartments appears.
Detection of C4d in glomeruli of healthy subjects, including two
children, supports the idea that fixation of 1gM-complexes to
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glomerular and certain arteriolar basement membranes may be
a common route for the catabolism of antigen-IgM complexes
formed during natural antibody response in vivo.
Finally, it should be noted that the classical pathway of
complement activation is a powerful tool for the elimination of
ICs [231. It seems quite likely therefore, that the glomerular C4d
fragments represent the remnant of a continuous physiological
clearance mechanism. This would also contribute to understand
the propensity to renal IC injury in persons with inherited
complement deficiencies [2, 43].
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